Published: Sep, 2018

The global meningococcal vaccines market comprises good number of established companies that are focusing on expanding market shares. According to report by Transparency Market Research, the competition in the market is rising since the past decade mainly owing to leading players introducing innovative business strategies in the market. This is majorly due to continuous entry of new players in the market.

Companies engaged in pharmaceutical industry can easily manufacture meningococcal vaccines to expand their horizon in the market by making a valuable change in the area of disease management. This is the prime factor for entrance of new players in the market. The established players in the market have attained skillful level of expertise in marketing of products, sale, and manufacturing of products that is resulting in enhanced growth prospective for the players in the market. Small vendors in the market are forming strategic alliances so as to counter strong foothold of leading players. The leading players in the market are experts in conducting core research in the field of meningococcal vaccines.

Some of the leading players operating in the global meningococcal vaccines market are Baxter International Inc., Biomed Pvt. Ltd., Pfizer Inc., Serum Institute of India Ltd., and Novartis International AG.

The global meningococcal vaccines market is expected to rise at a healthy CAGR of 12.40% during the forecast period of 2014 to 2022. The global market is expected to attain a valuation of US$4,450.4 mn by the end of 2022. The global meningococcal vaccines product segment is led by combination vaccines segment and it is expected to emerge as a prominent modality in the coming years owing to its helpful prevention in infants and toddlers. Geographically, the meningococcal market is led by North America and is anticipated to dominate the market during the forecast period due to substantial growth of  public awareness in this region.

Rising Incidence of Meningococcal Diseases Providing Lucrative Growth of Meningococcal Vaccines Market

The global meningococcal vaccines market is growing rapidly owning to rise in mortality and morbidity of meningococcal diseases among large populations. Technological advancement has massively reduced the burden of meningococcal disease. Governments across the globe are spreading awareness through campaigns in various parts of the globe is also boosting the market for meningococcal vaccines. The advancement in vaccinology has successfully improved public health. Implementation of vaccination programs in various countries such as sub-Saharan Africa and others are supplementing the market. The market is also driven by infant immunization and awareness campaign programs by government in various regions. Several health protection agencies are also taking initiatives to recommend vaccination of preteens and teens have boosted the market. The wide range of factor leading to occurrence of meningococcal disease gives impetus to the growth of global meningococcal vaccines market. This has led pharmaceutical companies to enter the market and manufacture meningococcal vaccines thus, boosting the market for the same.

Cost War to Hamper Market Growth

The global meningococcal vaccines market is expected to face certain restrains that might hamper the growth of the market. There is rise in drug makers making similar vaccines that have led to cost war in the market. The market cannot penetrate into regions with strict regulation, thus causing hindrance to the global market growth. Several regions have stringent regulatory framework that obstruct the manufacturing of drugs in this region. Several attempts to build strong base for research and development of antibodies have failed in various regions of the world such as Europe. Therefore, the market is expecting sluggish growth during the forecast period. 

The information in this review is based on the findings of a report by Transparency Market Research, titled “Meningococcal Vaccines Market (Polysaccharide, Conjugate, Combination and Men B Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”

The global meningococcal vaccines market is segmented as follow:

Meningococcal Vaccines Market, by Type

  • Polysaccharide Vaccines, by Brand
    • Menomune
    • Mencevax
    • NmVac4
    • Others
      • Quadri Meningo
      • Bi Meningo
    • Conjugate Vaccines, by Brand
      • Menactra
      • Menveo
      • NeisVac-C
      • Nimenrix
      • Meningitec
      • Menjugate
      • MenAfriVac
      • NmVac4-DT
    • Combination Vaccines, by Brand
      • MenHibrix
      • Menitorix
    • Men B Vaccines, by Brand
      • Bexsero
      • Trumenba

Meningococcal Vaccines Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com  
Website: https://www.transparencymarketresearch.com 

.